{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:27:48Z","timestamp":1786116468004,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,6]]},"group-title":"In Review","reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 TW011365 and D43TW012481-01"],"award-info":[{"award-number":["R21 TW011365 and D43TW012481-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,4]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\n Monitoring medication-related side effects is essential to tuberculosis (TB) pharmacovigilance, yet remains challenging in resource-limited settings. Video directly observed therapy (VDOT) offers an opportunity to capture patient-reported side effects in real time. This study characterized TB medication side effects reported through VDOT.\nMethods\n We conducted a secondary analysis of 68 adults treated for drug-susceptible TB in a randomized VDOT trial in Kampala, Uganda, during 2020\u20132021. Side effects were recorded longitudinally through the VDOT platform. A severity-weighted burden score was developed from reporting frequency and severity, and latent class analysis identified burden subgroups.\nResults\n Median age was 30 years; 50% were female and 31% were living with HIV. The most frequent side effects were joint\/body pain (84%), body weakness (79%), and red\/discolored urine (68%). Higher burden scores were observed among participants aged\u2009&gt;\u200930 years (p\u2009=\u20090.030), people living with HIV (p\u2009=\u20090.023), smokers (p\u2009=\u20090.023), and those with lower TB knowledge (p\u2009=\u20090.033). Two subgroups emerged: High (66.2%) and Low Burden (33.8%).\nConclusions\n VDOT enabled longitudinal monitoring of medication-related side effects and revealed substantial variation in burden, along with associated factors. VDOT shows promise as a digital pharmacovigilance tool supporting patient-centered TB care. Future studies should evaluate its integration into routine TB programs.<\/p>","DOI":"10.21203\/rs.3.rs-10595035\/v1","type":"posted-content","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:56:07Z","timestamp":1786010167000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterizing Tuberculosis Medication Side Effects Using Video Directly Observed Therapy Monitoring in Uganda: Opportunities for Digital Pharmacovigilance"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-1396","authenticated-orcid":false,"given":"Juliet N.","family":"Sekandi","sequence":"first","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7738-3104","authenticated-orcid":false,"given":"Kelvin","family":"Bwambale","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alif","family":"Indiralarasati","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen K.","family":"Kalembe","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisha","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damalie","family":"Nakkonde","sequence":"additional","affiliation":[{"name":"Makerere University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zalwango","sequence":"additional","affiliation":[{"name":"Kampala Capital City Authority"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","first-page":"19","article-title":"Tuberculosis: current challenges and beyond","author":"Villar-Hern\u00e1ndez R","year":"2023","unstructured":"Villar-Hern\u00e1ndez R et al (2023) Tuberculosis: current challenges and beyond. Breathe, 19","journal-title":"Breathe"},{"key":"ref2","volume-title":"Global Tuberculosis Report","author":"WHO","year":"2024","unstructured":"WHO (2024) Global Tuberculosis Report. Geneva"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.35942\/ijcab.v4i1.114","article-title":"Adherence to Pulmonary Tuberculosis Treatment in Murang'a County, Kenya","volume":"4","author":"Gitonga C","year":"2020","unstructured":"Gitonga C, Nyamari J, Mugo J (2020) Adherence to Pulmonary Tuberculosis Treatment in Murang'a County, Kenya. Int J Curr Aspects 4(1):49\u201363","journal-title":"Int J Curr Aspects"},{"key":"ref4","volume-title":"A Practical Handbook on The Pharmacovigilance of Medicines Used in The Treatment of Tuberculosis - Enhancing The Safety of The TB Patient","author":"WHO","year":"2012","unstructured":"WHO (2012) A Practical Handbook on The Pharmacovigilance of Medicines Used in The Treatment of Tuberculosis - Enhancing The Safety of The TB Patient. World Health Organization: France"},{"issue":"2","key":"ref5","first-page":"44","article-title":"Effectiveness of the DOTS Program in Enhancing Management of Pulmonary Tuberculosis: A Systematic Review","volume":"14","author":"Hayudini M","year":"2025","unstructured":"Hayudini M et al (2025) Effectiveness of the DOTS Program in Enhancing Management of Pulmonary Tuberculosis: A Systematic Review. Front Health Inf 14(2):44\u201351","journal-title":"Front Health Inf"},{"key":"ref6","first-page":"20","article-title":"'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa","author":"Moodley N","year":"2020","unstructured":"Moodley N et al (2020) 'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa. BMC Public Health, 20","journal-title":"BMC Public Health"},{"issue":"10","key":"ref7","article-title":"Effectiveness of Video-Observed Therapy in Tuberculosis Management: A Systematic Review","volume":"16","author":"Sundaram K","year":"2024","unstructured":"Sundaram K et al (2024) Effectiveness of Video-Observed Therapy in Tuberculosis Management: A Systematic Review. Cureus, 16(10)","journal-title":"Cureus"},{"key":"ref8","volume-title":"Using a Mobile Health Intervention (DOT Selfie) with Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial","author":"Sekandi J","year":"2021","unstructured":"Sekandi J et al (2021) Using a Mobile Health Intervention (DOT Selfie) with Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial, vol 10. JMIR Research Protocols, 1"},{"issue":"1","key":"ref9","first-page":"80","article-title":"Compliance Level and Side Effects in the Treatment of Tuberculosis Patients: A Study from Indonesia","volume":"7","author":"Sukmawan Y","year":"2024","unstructured":"Sukmawan Y, Rahayuningsih N, Hidayat M (2024) Compliance Level and Side Effects in the Treatment of Tuberculosis Patients: A Study from Indonesia. J Health Med Sci 7(1):80\u201384","journal-title":"J Health Med Sci"},{"key":"ref10","first-page":"18","article-title":"Patients' experiences and perceptions on associates of TB treatment adherence: a qualitative study on DOTS service in public health centers in Addis Ababa, Ethiopia","author":"Sahile Z","year":"2018","unstructured":"Sahile Z, Yared A, Kaba M (2018) Patients' experiences and perceptions on associates of TB treatment adherence: a qualitative study on DOTS service in public health centers in Addis Ababa, Ethiopia. BMC Public Health, 18","journal-title":"BMC Public Health"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/ijerph21121662","article-title":"Adherence to Pulmonary Tuberculosis Medication and Associated Factors Among Adults: A Cross-Sectional Study in the Metinaro and Becora Sub-Districts, Dili, Timor-Leste","volume":"21","author":"Fernandes A","year":"2024","unstructured":"Fernandes A et al (2024) Adherence to Pulmonary Tuberculosis Medication and Associated Factors Among Adults: A Cross-Sectional Study in the Metinaro and Becora Sub-Districts, Dili, Timor-Leste. Int J Environ Res Public Health 21(12):1662","journal-title":"Int J Environ Res Public Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijtb.2024.05.005","article-title":"Anti-TB treatment non-adherence predictors: A multi-center cross-sectional study in Kandahar, Afghanistan","volume":"72","author":"Stanikzai M","year":"2025","unstructured":"Stanikzai M et al (2025) Anti-TB treatment non-adherence predictors: A multi-center cross-sectional study in Kandahar, Afghanistan. Indian J Tuberculosis 72:298\u2013303","journal-title":"Indian J Tuberculosis"},{"key":"ref13","first-page":"12","article-title":"Adverse Event Burden Score\u2014A Versatile Summary Measure for Cancer Clinical Trials","author":"Le-Redemacher J","year":"2020","unstructured":"Le-Redemacher J et al (2020) Adverse Event Burden Score\u2014A Versatile Summary Measure for Cancer Clinical Trials. Cancers, 12","journal-title":"Cancers"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(16)00038-3","article-title":"Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254","volume":"17","author":"Thanarajasingam G","year":"2016","unstructured":"Thanarajasingam G et al (2016) Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254. Lancet Oncol 17:663\u2013670","journal-title":"Lancet Oncol"},{"key":"ref15","author":"Institute NC","year":"2017","unstructured":"Institute NC (2017) Common Terminology Criteria for Adverse Event (CTCAE) Version 5.0, U.S.D.o.H.a.H. Services, Editor"},{"key":"ref16","first-page":"61","article-title":"The Adverse Effects of Tuberculosis Treatment: A Comprehensive Literature Review","author":"Mere\u0161kevi\u02c7cien\u02d9 R","year":"2025","unstructured":"Mere\u0161kevi\u02c7cien\u02d9 R, Danila E (2025) The Adverse Effects of Tuberculosis Treatment: A Comprehensive Literature Review. Medicina, 61","journal-title":"Medicina"},{"key":"ref17","first-page":"3","volume-title":"Treatment of Tuberculosis and The Drug Interactions Associated with HIV-TB Co-Infection Treatment","author":"Pooranagangadevi N","year":"2022","unstructured":"Pooranagangadevi N, Padmapriyadarsini C (2022) Treatment of Tuberculosis and The Drug Interactions Associated with HIV-TB Co-Infection Treatment. Frontiers in Tropical Diseases, p 3"},{"key":"ref18","first-page":"10","author":"Caraux-Paz P","year":"2021","unstructured":"Caraux-Paz P et al (2021) Tuberculosis Elder J Clin Med, 10","journal-title":"Tuberculosis Elder J Clin Med"},{"key":"ref19","first-page":"13","article-title":"Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis","author":"Feldman C","year":"2024","unstructured":"Feldman C et al (2024) Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis. Pathogens, 13","journal-title":"Pathogens"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10595035\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10595035\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:56:14Z","timestamp":1786010174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10595035\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10595035\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,6]]},"subtype":"preprint"}}